These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 39193691)
21. Spesolimab: A Novel Treatment for Pustular Psoriasis. Ratnarajah K; Jfri A; Litvinov IV; Netchiporouk E J Cutan Med Surg; 2020; 24(2):199-200. PubMed ID: 32208020 [No Abstract] [Full Text] [Related]
22. Acrodermatitis continua of Hallopeau and generalised pustular psoriasis: Should they be the same or different entities? Chularojanamontri L; Rattanakorn K; Julanon N; Chuamanochan M; Griffiths CEM Exp Dermatol; 2023 Aug; 32(8):1235-1245. PubMed ID: 37057764 [TBL] [Abstract][Full Text] [Related]
23. Squamous cell carcinoma mimicking acrodermatitis continua suppurativa in a patient with generalized pustular psoriasis. Balestri R; Magnano M; Ioris T; Girardelli CR; Rech G J Dtsch Dermatol Ges; 2023 May; 21(5):537-539. PubMed ID: 36960854 [No Abstract] [Full Text] [Related]
25. Pustular psoriasis and acrodermatitis continua (Hallopeau) need high doses of systemic ciclosporin A. Korstanje MJ; Bessems PJ; Hulsmans RF; van de Staak WJ Dermatologica; 1989; 179(2):90-1. PubMed ID: 2792497 [No Abstract] [Full Text] [Related]
26. Using oral tetracycline and topical betamethasone valerate to treat acrodermatitis continua of hallopeau. Piquero-Casals J; Fonseca de Mello AP; Dal Coleto C; Fonseca Takahashi MD; Simonsen Nico MM Cutis; 2002 Aug; 70(2):106-8. PubMed ID: 12234156 [TBL] [Abstract][Full Text] [Related]
27. A case of acrodermatitis continua of Hallopeau successfully treated with guselkumab. Buononato D; Licata G; Gambardella A; De Rosa A; Calabrese G; Argenziano G Dermatol Ther; 2022 Jul; 35(7):e15514. PubMed ID: 35420733 [No Abstract] [Full Text] [Related]
28. A brief guide to pustular psoriasis for primary care providers. Crowley JJ; Pariser DM; Yamauchi PS Postgrad Med; 2021 Apr; 133(3):330-344. PubMed ID: 33118424 [TBL] [Abstract][Full Text] [Related]
29. Treatment of acrodermatitis continua of Hallopeau with adalimumab. Ryan C; Collins P; Kirby B; Rogers S Br J Dermatol; 2009 Jan; 160(1):203-5. PubMed ID: 18945314 [No Abstract] [Full Text] [Related]
30. First emergence of pyoderma gangraenosum, palmoplantar pustulosis and sacroiliitis in a psoriasis patient associated with switching from secukinumab to brodalumab. Sadik CD; Thieme M; Zillikens D; Terheyden P J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):e406-e407. PubMed ID: 31131924 [No Abstract] [Full Text] [Related]
31. Pustular psoriasis: pathophysiology and current treatment perspectives. Benjegerdes KE; Hyde K; Kivelevitch D; Mansouri B Psoriasis (Auckl); 2016; 6():131-144. PubMed ID: 29387600 [TBL] [Abstract][Full Text] [Related]
32. Successful secukinumab treatment of generalized pustular psoriasis. Guo HS; Zhou XL; Chen HH; Hu T; Liu MH; Liu FY; Ma LL; Li WQ Dermatol Online J; 2024 Mar; 30(1):. PubMed ID: 38762856 [TBL] [Abstract][Full Text] [Related]
33. Acrodermatitis continua of Hallopeau: treatment with etretinate and review of relapsing pustular eruptions of the hands and feet. Pearson LH; Allen BS; Smith JG J Am Acad Dermatol; 1984 Oct; 11(4 Pt 2):755-62. PubMed ID: 6491002 [TBL] [Abstract][Full Text] [Related]
34. The profile and outcome of pustular psoriasis in Singapore: a report of 28 cases. Tay YK; Tham SN Int J Dermatol; 1997 Apr; 36(4):266-71. PubMed ID: 9169323 [TBL] [Abstract][Full Text] [Related]
35. Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study. Gisondi P; Bellinato F; Girolomoni G Vaccines (Basel); 2022 Jul; 10(8):. PubMed ID: 35893820 [TBL] [Abstract][Full Text] [Related]
36. The successful use of etanercept in combination therapy for treatment of acrodermatitis continua of hallopeau. Kazinski K; Joyce KM; Hodson D J Drugs Dermatol; 2005; 4(3):360-4. PubMed ID: 15898294 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3). Menter A; Warren RB; Langley RG; Merola JF; Kerr LN; Dennehy EB; Shrom D; Amato D; Okubo Y; Reich K J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1686-1692. PubMed ID: 28322474 [TBL] [Abstract][Full Text] [Related]
38. Pustular Psoriasis: The Dawn of a New Era. Bachelez H Acta Derm Venereol; 2020 Jan; 100(3):adv00034. PubMed ID: 31971600 [TBL] [Abstract][Full Text] [Related]